Assistant Professor Quanyin Hu has developed a new method for targeting tumors with cancer drugs by exploiting the clotting propensity of blood platelets.
tumor
New Approach Could Push Limits of Immunotherapy for Difficult-to-Treat Cancers
A recent study by Assistant Professor Quanyin Hu points toward a potential new approach for pushing the limits of immunotherapy, opening a door to more effective treatment of inoperable tumors and metastatic cancer.
New Injectable Gel Treatment Offers Promise for Tough-to-Treat Brain Tumors
School of Pharmacy Assistant Professor Quanyin Hu and collaborators publish preclinical results on a new approach to prevent glioblastoma recurrence.